Registration Number
0214U005301,
0111U010127
, R & D reports
Title
To study the patogenetic mechanisms of immunological disorders caused by violation of gamma interferon production and reception in patients with destructive pulmonary tuberculosis
popup.stage_title
Head
Rekalova Elena Myhaylovna,
Registration Date
16-01-2015
Organization
SO "National institute of phthisiology and pulmonology named after F. G. Yanovsky NAMS of Ukraine"
popup.description2
Object - 70 patients with destructive pulmonary tuberculosis and 30 healthy subjects. Aim - to work out of technology use drugs interferon and of inducers in patients with destructive pulmonary tuberculosis by examining variations in the interferon system disorders based on data analysis of specific and nonspecific immune resistance. Methods - clinical, immunological, statistical. Were established, that mononuclear immune deficiency (MIN) occurs in almost all patients on the DTBL (99%) and in 73 % patients these changes were profound (third degree) and were combined with a combination of depressions of T-, B- cells and monocytes (57 %). Developed by: technology identify additional criteria mononuclear immune deficiency on indicators system g-IFN and technology identify additional criteria for assessing the functional status of circulating phagocytes. Highlighted four main variants of changes in g-IFN, that accompanied by inhibition of effectors cell function of the immune defense. Principles were grounded of rational immunotherapy using drugs g-IFN and its inducers and were offered its scheme. Developed method for immunotherapy in patients with pulmonary tuberculosis and determining the indications for the use of bacterial peptidoglycan Blastomunil to correct the system g-IFN. Developed method for the treatment of patients with pulmonary tuberculosis, which helps normalize the system of g-IFN and immune system as a whole, which increases the effectiveness of treatment by reducing in 1,9 times the timing resolution of infiltrative changes in the lungs, increasing 2,2 times the percentage of patients, in which disappeared the cavity in the lungs and were reduced in 1,3 times periods of stay of patients in hospital. Sphere of application - phthisiology, pulmonology, immunology
Product Description
popup.authors
Ільинська Ірина Федорівна
Зубрійчук Оксана Миколаївна
Кадан Людмила Павлівна
Коваль наталія Григорівна
Копосова Ірина Вікторовна
Литвиненко Наталія Олександрівна
Матвієнко Юлія Олександрівна
Панасюкова Оксана Романівна
Петішкіна Валерія Миколаївна
Рева Олена Олександрівна
Рекалова Олена Михайлівна
Сінгаєвський Мирослав Богдановия
Фірсова Ала Сергіївна
Чернушенко Катерина Федорівна
Ясир Світлана Григорівна
popup.nrat_date
2020-04-02
